Evidence map›Paper›PMID 27433484›Full record

ReviewInternational scholarly research notices2014

C-Reactive Protein: An In-Depth Look into Structure, Function, and Regulation.

Juan Salazar, María Sofía Martínez, Mervin Chávez-Castillo, Victoria Núñez, Roberto Añez, Yaquelin Torres, Alexandra Toledo, Maricarmen Chacín, Carlos Silva, Enrique Pacheco and 2 more

Abstract readReview
In one paragraph

Review in International scholarly research notices, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Review
  6. Article
  7. Observational
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. C-reactive protein impairs immune response of CD8Journal for immunotherapy of cancer · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Juan SalazarEndocrine and Metabolic Diseases Research Center, School of Medicine, Zulia University, 20th Avenue, Maracaibo 4004, Venezuela.
María Sofía MartínezEndocrine and Metabolic Diseases Research Center, School of Medicine, Zulia University, 20th Avenue, Maracaibo 4004, Venezuela.
Mervin Chávez-CastilloEndocrine and Metabolic Diseases Research Center, School of Medicine, Zulia University, 20th Avenue, Maracaibo 4004, Venezuela.
Victoria NúñezEndocrine and Metabolic Diseases Research Center, School of Medicine, Zulia University, 20th Avenue, Maracaibo 4004, Venezuela.
Roberto AñezEndocrine and Metabolic Diseases Research Center, School of Medicine, Zulia University, 20th Avenue, Maracaibo 4004, Venezuela.
Yaquelin TorresEndocrine and Metabolic Diseases Research Center, School of Medicine, Zulia University, 20th Avenue, Maracaibo 4004, Venezuela.
Alexandra ToledoEndocrine and Metabolic Diseases Research Center, School of Medicine, Zulia University, 20th Avenue, Maracaibo 4004, Venezuela.
Maricarmen ChacínEndocrine and Metabolic Diseases Research Center, School of Medicine, Zulia University, 20th Avenue, Maracaibo 4004, Venezuela.
Carlos SilvaEndocrine and Metabolic Diseases Research Center, School of Medicine, Zulia University, 20th Avenue, Maracaibo 4004, Venezuela.
Enrique PachecoEndocrine and Metabolic Diseases Research Center, School of Medicine, Zulia University, 20th Avenue, Maracaibo 4004, Venezuela.
Joselyn RojasEndocrine and Metabolic Diseases Research Center, School of Medicine, Zulia University, 20th Avenue, Maracaibo 4004, Venezuela; Institute of Clinical Immunology, University of Los Andes, Mérida 5101, Mérida, Venezuela.
Valmore BermúdezEndocrine and Metabolic Diseases Research Center, School of Medicine, Zulia University, 20th Avenue, Maracaibo 4004, Venezuela.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular disease is the leading cause of morbidity and mortality in the adult population worldwide, with atherosclerosis being its key pathophysiologic component. Atherosclerosis possesses a fundamental chronic inflammatory aspect, and the involvement of numerous inflammatory molecules has been studied in this scenario, particularly C-reactive protein (CRP). CRP is a plasma protein with strong phylogenetic conservation and high resistance to proteolysis, predominantly synthesized in the liver in response to proinflammatory cytokines, especially IL-6, IL-1β, and TNF. CRP may intervene in atherosclerosis by directly activating the complement system and inducing apoptosis, vascular cell activation, monocyte recruitment, lipid accumulation, and thrombosis, among other actions. Moreover, CRP can dissociate in peripheral tissue-including atheromatous plaques-from its native pentameric form into a monomeric form, which may also be synthesized de novo in extrahepatic sites. Each form exhibits distinct affinities for ligands and receptors, and exerts different effects in the progression of atherosclerosis. In view of epidemiologic evidence associating high CRP levels with cardiovascular risk-reflecting the biologic impact it bears on atherosclerosis-measurement of serum levels of high-sensitivity CRP has been proposed as a tool for assessment of cardiovascular risk.

Identifiers

PMID27433484
PMCPMC4897210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.